ATE410423T1 - Gemische zur behandlung oder prävention von malaria und verfahren zur behandlung von malaria - Google Patents

Gemische zur behandlung oder prävention von malaria und verfahren zur behandlung von malaria

Info

Publication number
ATE410423T1
ATE410423T1 AT01925951T AT01925951T ATE410423T1 AT E410423 T1 ATE410423 T1 AT E410423T1 AT 01925951 T AT01925951 T AT 01925951T AT 01925951 T AT01925951 T AT 01925951T AT E410423 T1 ATE410423 T1 AT E410423T1
Authority
AT
Austria
Prior art keywords
treating
malaria
mixtures
methods
preventing
Prior art date
Application number
AT01925951T
Other languages
English (en)
Inventor
Tomio Takeuchi
Yusuke Wataya
Munekazu Iinuma
Hye-Sook Kim
Hiroomi Watabe
Hiroshi Naganawa
Yoshikazu Takahashi
Original Assignee
Zaidan Hojin Biseibutsu
Meiji Seika Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zaidan Hojin Biseibutsu, Meiji Seika Kaisha filed Critical Zaidan Hojin Biseibutsu
Application granted granted Critical
Publication of ATE410423T1 publication Critical patent/ATE410423T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT01925951T 2000-04-26 2001-04-26 Gemische zur behandlung oder prävention von malaria und verfahren zur behandlung von malaria ATE410423T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000126369 2000-04-26

Publications (1)

Publication Number Publication Date
ATE410423T1 true ATE410423T1 (de) 2008-10-15

Family

ID=18636160

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01925951T ATE410423T1 (de) 2000-04-26 2001-04-26 Gemische zur behandlung oder prävention von malaria und verfahren zur behandlung von malaria

Country Status (8)

Country Link
US (1) US6939892B2 (de)
EP (1) EP1295881B1 (de)
JP (1) JP4806510B2 (de)
AT (1) ATE410423T1 (de)
AU (1) AU5259801A (de)
CA (1) CA2411966C (de)
DE (1) DE60136067D1 (de)
WO (1) WO2001081339A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6547139B1 (en) 1998-07-10 2003-04-15 Welch Allyn Data Collection, Inc. Method and apparatus for extending operating range of bar code scanner
WO2009039483A1 (en) * 2007-09-21 2009-03-26 Omnicare Inc. Automated label verify systems and methods for dispensing pharmaceuticals

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4283493A (en) * 1978-09-22 1981-08-11 Hoffmann-La Roche Inc. Process of producing antibiotic X-14766A by a streptomyces
US4221724A (en) * 1978-09-22 1980-09-09 Hoffmann-La Roche Inc. Antibiotic X-14766A
AU531276B2 (en) * 1978-11-29 1983-08-18 F. Hoffmann-La Roche & Co. Antibacterial urethane derivatives
JPS5592387A (en) * 1978-12-29 1980-07-12 Taisho Pharmaceut Co Ltd Antibiotic substance tm-531
US4375542A (en) * 1980-01-17 1983-03-01 Schering Corporation Kijanimicin antibiotics and derivatives thereof
JPS5978120A (ja) * 1982-10-28 1984-05-04 Meiji Seika Kaisha Ltd 抗ウイルス剤
US4496549A (en) * 1983-01-17 1985-01-29 American Cyanamid Company Treatment of malaria with antibiotics
US4578468A (en) * 1984-03-26 1986-03-25 American Cyanamid Company Antibiotic LL-D42067β
US4859598A (en) * 1984-03-26 1989-08-22 American Cyanamid Company Antibiotic LL-D42067β
US4551533A (en) * 1984-03-26 1985-11-05 American Cyanamid Company Antibiotic LL-D42067α
US4774184A (en) * 1984-03-26 1988-09-27 American Cyanamid Company Culture and process for producing antibiotic LL-D42067alpha
US4650802A (en) * 1984-03-26 1987-03-17 American Cyanamid Company Methods and compositions for treating protozoal infections with a novel antibiotic
JPS63192792A (ja) * 1987-02-06 1988-08-10 Meiji Seika Kaisha Ltd 新規抗生物質ｓｆ２４８７物質及びその製造法
IL87300A (en) * 1987-08-13 1992-09-06 Lilly Co Eli Antibiotic a80577,derivatives thereof,process for their production and feed compositions containing them
US4876273A (en) * 1987-08-13 1989-10-24 Eli Lilly And Company Antibotic A80577 and process for its production
US5098834A (en) * 1988-05-02 1992-03-24 Eli Lilly And Company Process for producing antibiotic A8210 which comprises cultivating Actinomadura Fibrosa sp nov. NRRL 18348, or an A82810-producing mutant thereof

Also Published As

Publication number Publication date
EP1295881B1 (de) 2008-10-08
US20030176492A1 (en) 2003-09-18
AU5259801A (en) 2001-11-07
US6939892B2 (en) 2005-09-06
JP4806510B2 (ja) 2011-11-02
CA2411966C (en) 2008-11-18
DE60136067D1 (de) 2008-11-20
CA2411966A1 (en) 2002-12-05
EP1295881A1 (de) 2003-03-26
WO2001081339A1 (fr) 2001-11-01
EP1295881A4 (de) 2006-10-18

Similar Documents

Publication Publication Date Title
DE69324120T2 (de) HIV-Proteaseinhibitoren und ihre Verwendung zur Behandlung von AIDS
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
DE69334250D1 (de) Verfahren und Intermediate zur Herstellung von retroviralen Proteasehemmern
ATE487493T1 (de) Azolsäure-derivate, allein oder kombiniert, zur behandlung von diabetes und dyslipidaemien; und zur behandlung von malignen erkrankungen
DE60219292D1 (de) Pyrazolderivate zur behandlung von hiv
CY1107539T1 (el) Παραγωγα κουιναζολινης
DE69925256D1 (de) Trisubstituierte 1,3,5-triazine derivate zur behandlung von hiv infektionen
ATE362758T1 (de) Indomethacin-amidderivate zur antiangiogenen und/oder antitumorigen verwendung
ATE188377T1 (de) Chinoline oder chinazolin-derivate und deren verwendung zur herstellung eines medikaments für die behandlung von osteoporose
DE69227571T2 (de) Zusammensetzung, verfahren und instrument zur potenzierung der antitumoraktivität und zur behandlung von tumoren
ATE209199T1 (de) Chinolin und chinazolin derivate zur behandlung von arthritis
DE69936285D1 (de) INDOLOi2,1-BöQUINAZOLIN-6,12-DIONE ANTIMALARIA DERIVATE UND METHODEN ZUR BEHANDLUNG VON MALARIA
DE60220043D1 (de) Carbamatverbindungen zur vorbeugung oder behandlung von neurodegenerativen störungen
FI935777A (fi) AIDSin hoitamisessa käyttökelpoiset HIV-proteaasin inhibiittorit
ATE312079T1 (de) Nichtnukleoside reverse transkriptase-hemmer zur behandlung von hiv-infektion
DE60221670D1 (de) Carbamatverbindungen zur vorbeugung und behandlung von bewegungsstörungen
DE60211913D1 (de) Aryl- (oder heteroaryl-) azolylcarbynolderivatve zur behandlung von harninkontinenz
ATE293973T1 (de) Naphtylisoquinolinalkaloiden, diese enthaltende pharmazeutische zusammensetzungen und ihre verwendung zur behandlung von malaria
DE60238765D1 (de) Carbamatverbindungen zur behandlung von schmerz
ATE410423T1 (de) Gemische zur behandlung oder prävention von malaria und verfahren zur behandlung von malaria
DK0604186T3 (da) HIV-proteaseinhibitorer, som er egnede til behandling af AIDS
DE69936186D1 (de) Dihydroartemisinin-Formulierung zur Behandlung von verschiedenen Typen von Malaria
ATE419238T1 (de) Arylsulfanyl und heteroarylsulfanyl-derivate zur behandlung von schmerz
DE60233740D1 (de) Benzoägüchinolinderivate zur behandlung von glaucom und kurzsichtigkeit
NZ534600A (en) Substituted isoquinoline derivatives and their use as anticonvulsants

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties